Parabilis Medicines, Inc. (PBLS)

Parabilis Medicines Statistics

Total Valuation

PBLS has a market cap or net worth of $3.29 billion. The enterprise value is $3.06 billion.

Market Cap	3.29B
Enterprise Value	3.06B

Important Dates

The next estimated earnings date is Tuesday, August 18, 2026.

Earnings Date	Aug 18, 2026
Ex-Dividend Date	n/a

Share Statistics

PBLS has 127.34 million shares outstanding.

Current Share Class	125.76M
Shares Outstanding	127.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	25.02%
Float	118.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	13.64
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.22.

Current Ratio	6.12
Quick Ratio	6.07
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-110.33

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-47.32%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.45M
Employee Count	145
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	2,201,741

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-156.12M
Pretax Income	-152.88M
Net Income	-209.71M
EBITDA	-153.67M
EBIT	-156.12M
Earnings Per Share (EPS)	-$67.09

Balance Sheet

The company has $329.04 million in cash and $53.15 million in debt, with a net cash position of $275.89 million or $2.17 per share.

Cash & Cash Equivalents	329.04M
Total Debt	53.15M
Net Cash	275.89M
Net Cash Per Share	$2.17
Equity (Book Value)	244.22M
Book Value Per Share	-174.15
Working Capital	277.83M

Cash Flow

In the last 12 months, operating cash flow was -$138.76 million and capital expenditures -$601,000, giving a free cash flow of -$139.36 million.

Operating Cash Flow	-138.76M
Capital Expenditures	-601,000
Depreciation & Amortization	2.45M
Net Borrowing	-6.85M
Free Cash Flow	-139.36M
FCF Per Share	-$1.09

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PBLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.30%
FCF Yield	-4.18%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1

Data Source: S&P Global Market Intelligence Last updated: Jun 18, 2026

Financial statistics are provided by S&P Global Market Intelligence. Financial numbers update within hours after each earnings release, while price-based statistics and ratios update throughout each trading day.

Update frequency:

Daily

Last checked:

Jun 18, 2026

Data Sources Report a data error